Attention AACR-NCI-EORTC Molecular Targets Conference Registrants - Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Lessons from the BRAF-targeted Therapy of Melanoma

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Changing cell fate in cancer: Lessons from melanoma
Leonard I. Zon
Harvard Medical School, Children's Hospital, Boston, MA, United States
from 2011 Molecular Targets and Cancer Therapeutics conference on November 13, 2011 2:30 PM-4:30 PM
BRAF and RAS signaling in cancer: From biology to therapeutics
Richard M. Marais
Institute of Cancer Research, London, United Kingdom
from 2011 Molecular Targets and Cancer Therapeutics conference on November 13, 2011 2:30 PM-4:30 PM
BRAF and MEK inhibition in melanoma
Tona M. Gilmer
GlaxoSmithKline, Research Triangle Park, NC, United States
from 2011 Molecular Targets and Cancer Therapeutics conference on November 13, 2011 2:30 PM-4:30 PM
ERK pathway inhibitors in melanoma -- sensitivity and resistance
Neal Rosen
Memorial Sloan-Kettering Cancer Center, New York, NY, United States
from 2011 Molecular Targets and Cancer Therapeutics conference on November 13, 2011 2:30 PM-4:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4